- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: IDEAL-E observation (investigators choice of imatinib, nilotinib, dasatinib, radotinib)
Total 6 results
-
Asan Medical CenterWithdrawnLeukemia, Myelogenous, Chronic, BCR-ABL PositiveKorea, Republic of
-
Boehringer IngelheimCompletedBreast Neoplasms | Neoplasm MetastasisUnited States, Canada, Finland, France, Germany, Italy, Korea, Republic of, Spain
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungAustria, Germany, Spain, China, Taiwan, Argentina, Australia, Belgium, Brazil, Finland, France, Hungary, India, Israel, Italy, Korea, Republic of, Mexico, Netherlands, Peru, Poland, Russian Federation, Ukraine, United Kingdom
-
Institut CurieUnknownReccurent/Metastatic Solid Tumor DiseaseFrance
-
Peking Union Medical CollegePeking University Hospital of StomatologyRecruitingPrecision Therapy | Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma | Neoadjuvant or Conversion TherapyChina
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States